ArticlemedRxiv : the preprint server for health sciences2025
Neurobehavioral Signatures in Overgrowth Intellectual Disability Syndromes: Dissecting Genotype-Phenotype Relationships in the PI3K-AKT-MTOR Pathway.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Qualitative Study of the Treatment Experiences of Autistic Adults Allocated to Sertraline or Placebo for Anxiety in a Blinded Randomised Controlled Trial.Journal of autism and developmental disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Overgrowth intellectual disability syndromes (OGIDs) caused by mutations in the PI3K-AKT-MTOR pathway present significant neurobehavioral challenges. While PTEN Hamartoma Tumor Syndrome (PHTS) has been behaviorally characterized, Smith-Kingsmore Syndrome (SKS) has not, limiting our understanding of shared and unique features across OGIDs. We conducted comprehensive neurobehavioral assessments in 17 individuals with SKS and compared them to previously characterized cohorts with PHTS (n=74), macrocephaly-associated autism (n=33), and healthy controls (n=32). Assessments included standardized measures of motor coordination, adaptive functioning, social interaction, and executive functioning. We performed genotype-phenotype correlation analyses and developed diagnostic classification models using recursive partitioning. Individuals with SKS showed significant impairments across multiple domains compared to controls. Compared to the PTEN-ASD group, SKS individuals demonstrated particularly severe deficits in motor coordination and adaptive functioning, while executive functioning and behavioral regulation were similarly impaired. Novel clinical features were identified, including immune dysregulation and chronic constipation in SKS, and notably high rates of neonatal teeth (44.7%) in PHTS. Diagnostic classification models incorporating both behavioral and medical features achieved above-chance accuracy in distinguishing between conditions, with neonatal teeth emerging as a key distinguishing feature for PHTS. Domain-specific analyses showed variants in the PTEN phosphatase domain were associated with more severe social and executive function deficits compared to C2 domain variants. Correlation analyses between variant pathogenicity scores and clinical measures revealed limited consistent associations, though Combined Annotation Dependent Depletion (CADD) scores showed stable correlations with sensory processing measures across cohorts. Our findings establish distinct neurobehavioral profiles between SKS and PHTS, suggesting different impacts of MTOR versus PTEN mutations on neural circuit development. The identification of novel phenotypic features expands the clinical spectrum of these disorders and provides new diagnostic markers. The limited predictive value of variant pathogenicity scores for neurobehavioral outcomes emphasizes the need for comprehensive individual assessments. These results provide a foundation for developing targeted interventions while highlighting the complexity of genotype-phenotype relationships in PI3K-AKT-MTOR pathway disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.